TheEdgeResearch
Home / Stocks / GRPS

Trans American Aquaculture, Inc. (GRPS)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$180,593
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.16
52-Wk Range
0.0001-0.000500000024
CEO
Adam Thomas
Country
US
Currency
USD

Trans American Aquaculture, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $180,593. On trailing twelve-month figures it carries a trailing P/E of -0.33, a net margin of 0.0%. Its beta of 0.16 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.33
Price / Sales
0.00
Price / Book
-0.05
EV / EBITDA
-5.63
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.22
Current ratio
0.07
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
6
IPO date
1994-10-31
Headquarters
Dallas, TX, US
About Trans American Aquaculture, Inc.

Gold River Productions, Inc. focuses on developing and marketing plastic composite materials throughout the United States. These products find extensive use across numerous sectors, such as the commercial and leisure vehicle industry, the building and construction trade, and the maritime field, among others. The firm's corporate headquarters are situated in Salt Lake City, Utah.

Comparable companies

Trans American Aquaculture, Inc. is most often compared with the following Healthcare names:

DKSCFITXGEATFGRCUMSMYSLNXSTEKTRLFFVRTHFXBRAF
More research on GRPS
GRPS technical analysis GRPS TheEdge Score Compare against peers
Open full interactive analysis & DCF →